Key Drivers
- Negative free cash flow
- Elevated payout ratio
- Rising debt burden
AIAI Summary
SBRA is no longer simply a high-yield healthcare REIT: its upside depends on converting senior-housing occupancy gains and 7%–7.5% investments into durable AFFO, while investors should wait for cleaner credit performance and successful Avamere re-tenanting before treating the dividend and recovery as fully de-risked.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Negative free cash flow
- •Elevated payout ratio
- •Rising debt burden
SBRA offers a high dividend and solid operating cash flow, but negative free cash flow, weak dividend coverage, rising leverage, and recent quarterly losses warrant caution.
Price Behavior
Key Price Behavior Insights:
- •Repeated $21 rejection
- •Support under pressure
- •Weakening momentum
SBRA is in a short-term downtrend over the last month, testing $19.70–$19.75 support; bearish momentum persists below $20.15–$20.50, while a break lower could target $19.55.
Repeated failures near $21.00 highlight persistent selling pressure
Sentiment & News
Key News Insights:
- •AFFO Growth
- •Rising Occupancy
- •Strategic Investments
Sabra Health Care REIT's stronger AFFO, occupancy, and senior-housing investments support a positive growth outlook despite rate headwinds.
Improving fundamentals and disciplined expansion could strengthen Sabra's valuation and investor appeal
Similar Companies in Real Estate
Other companies in the same sector with AI ratings